Linda P.T. Joosten

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

Linda P.T. Joosten, Sander van Doorn, Peter M. van de Ven et al. · Circulation · 2023 · 167 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial

Linda P.T. Joosten, Sander van Doorn, Arno W. Hoes et al. · BMJ Open · 2019 · 22 citations · Full text

Pharmacy, Geriatric Medicine, Cardiovascular Pharmacotherapy +12

Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients

Joost A. Offerhaus, Linda P.T. Joosten, Maarten van Smeden et al. · IJC Heart & Vasculature · 2022 · 16 citations · Full text

Medicine, Internal Medicine, Clinical Cardiology +10

Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study

Florien S van Royen, Linda P.T. Joosten, Maarten van Smeden et al. · PLoS ONE · 2022 · 16 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16